drugset
drugset / Trial / NCT03752242

Evaluation of Topical Application of BMX-010 in Subjects With Acne Vulgaris.

NCT03752242 ↗

Phase 2 Terminated 2 enrolled BioMimetix JV, LLC
NaSingle-groupOpen-labelTreatment

Summary

This is an exploratory Phase 2 trial of BMX-010 in patients with Acne Vulgaris which will be conducted in two parts.

Timeline

Start
2019-01-03
Primary completion
2020-08-31
Completion
2020-08-31

Outcome

Outcome not reported

Stopped (Enrollment): “Enrollment stopped for chemistry work on investigational product.”

Drugs

EvaluationDrugModalityDoseRoute
Subject BMX-010 Unknown 0.03 % Topical

Indications

acne